Cara Therapeutics | CARA - Market Capitalization


Cara Therapeutics reported $193.1M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Alterity Therapeutics Limited AUD 40M 16M May/2026
Cara Therapeutics USD 366M 338M Sep/2025
Cassava Sciences USD 96M 45M Dec/2025
Chugai Pharma JPY 14.46T 617.89B Mar/2026
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
J&J USD 579.15B 78.91B Mar/2026
Neurocrine Biosciences USD 13.34B 800M May/2026
Pacira USD 915M 149M Mar/2026
Pfizer USD 148.08B 6.51B May/2026
RedHill Biopharma USD 12M 17M Jun/2024
Supernus Pharmaceuticals USD 2.66B 188M May/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024